Direxion Daily S&P Biotech Bull 3x Shares Rating $77.51 -0.46 (-0.59%) Closing price 04:10 PM EasternExtended Trading$77.33 -0.18 (-0.23%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Direxion Daily S&P Biotech Bull 3x Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LABU Aggregate RatingModerate Buy 2.70Holdings in LABU have an aggregate rating of Moderate Buy based on 412 analyst ratings issued in the past year covering 20 companies (30.3% of the portfolio).LABU Aggregate Price Target$77.51High Prediction$77.51Average Prediction$77.51Low Prediction$77.51Holdings in LABU have an aggregate price target of $77.51 and a range of $77.51 to $77.51 covering 20 companies (30.3% of the portfolio).LABU Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily S&P Biotech Bull 3x Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 20 LABU Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.15%ALNYAlnylam Pharmaceuticals$453.54+1.4%3.9894 of 5 stars2.85$412.79 -9.0%26News CoverageAnalyst Forecast1.86%INSMInsmed$142.53-0.7%3.781 of 5 stars2.94$134.79 -5.4%17Trending NewsAnalyst ForecastInsider TradeAnalyst Revision1.80%INCYIncyte$85.44-1.7%4.6639 of 5 stars2.33$82.53 -3.4%18News CoveragePositive NewsAnalyst ForecastShort Interest ↑1.78%HALOHalozyme Therapeutics$73.40-1.9%4.6856 of 5 stars2.33$67.11 -8.6%12Trending NewsAnalyst UpgradeInsider TradeAnalyst Revision1.62%UTHRUnited Therapeutics$380.47-2.8%4.7223 of 5 stars2.69$423.85 11.4%13Trending NewsAnalyst ForecastInsider TradeShort Interest ↑1.60%REGNRegeneron Pharmaceuticals$567.22+0.6%4.8153 of 5 stars2.81$817.67 44.2%27Positive NewsAnalyst Upgrade1.55%GILDGilead Sciences$112.77-0.2%4.9804 of 5 stars2.88$115.39 2.3%26Trending News1.54%ABBVAbbVie$212.77+0.4%4.7051 of 5 stars2.92$214.95 1.0%26Trending News1.53%NBIXNeurocrine Biosciences$140.40+3.2%4.8601 of 5 stars2.86$159.50 13.6%21Positive NewsShort Interest ↑1.50%BBIOBridgeBio Pharma$51.830.0%4.1821 of 5 stars3.00$63.35 22.2%17News CoveragePositive NewsAnalyst Forecast1.49%BIIBBiogen$139.94-1.2%4.8413 of 5 stars2.34$185.74 32.7%32Trending NewsAnalyst Forecast1.45%AMGNAmgen$280.10-1.3%4.661 of 5 stars2.32$304.43 8.7%22Trending NewsAnalyst Forecast1.44%BMRNBioMarin Pharmaceutical$56.75-3.8%4.9913 of 5 stars2.72$93.43 64.6%25News CoveragePositive NewsAnalyst Forecast1.44%MRNAModerna$24.28+1.0%4.4241 of 5 stars2.04$42.88 76.6%241.40%NTRANatera$166.56-0.6%3.1835 of 5 stars3.06$194.00 16.5%18Positive NewsAnalyst ForecastInsider Trade1.35%MDGLMadrigal Pharmaceuticals$431.21-0.9%4.1623 of 5 stars2.90$471.13 9.3%10News CoveragePositive NewsAnalyst Forecast1.32%EXELExelixis$37.38+1.1%4.816 of 5 stars2.52$44.06 17.9%23Analyst Revision1.24%VRTXVertex Pharmaceuticals$396.93+0.1%4.9841 of 5 stars2.56$497.10 25.2%27Positive NewsAnalyst Forecast1.17%EXASExact Sciences$51.41+4.3%4.8348 of 5 stars2.91$67.05 30.4%23Positive NewsShort Interest ↑Gap Up1.04%ROIVRoivant Sciences$12.57-0.2%3.17 of 5 stars3.20$16.38 30.3%5News CoveragePositive NewsAnalyst Forecast This page (NYSEARCA:LABU) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump’s national nightmare is hereWashington just added $1 trillion to the national debt in less than two months — an astonishing pace of spendi...Porter & Company | SponsoredWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LABU Stock Alerts